5-(N,N-dimethyl)-Amiloride Hydrochloride: Precision NHE1 Inhibition for pH and Ion Transport Research

Executive Summary: 5-(N,N-dimethyl)-Amiloride (hydrochloride) (DMA) is a crystalline derivative of amiloride, exhibiting potent inhibition of Na+/H+ exchanger (NHE) isoforms NHE1 (Ki = 0.02 μM), NHE2 (Ki = 0.25 μM), and NHE3 (Ki = 14 μM) [APExBIO]. DMA blocks proton extrusion and sodium uptake, disrupting intracellular pH and sodium homeostasis in mammalian cells (Chen et al., 2021). It demonstrates protective effects in cardiac ischemia-reperfusion injury by normalizing tissue Na+ and preserving contractile function [ddp-4.com]. DMA is highly soluble (up to 30 mg/ml) in DMSO/dimethylformamide and should be stored at -20°C. The compound is for research use only and is provided as a validated, stable hydrochloride salt by APExBIO.

Biological Rationale

The Na+/H+ exchanger (NHE) family regulates intracellular pH (pHi), sodium ion concentration, and cell volume in mammalian tissues. NHE1 is ubiquitously expressed and critical for pHi homeostasis, especially in cardiac and endothelial cells. Disruption of NHE activity leads to altered acid-base balance and impairs cellular recovery from ischemic or inflammatory insults (Chen et al., 2021). Selective NHE inhibition is a validated strategy for probing the physiological and pathological roles of sodium-proton exchange in cardiovascular, hepatic, and sepsis models. 5-(N,N-dimethyl)-Amiloride (hydrochloride) enables precise, isoform-targeted interrogation of these pathways, minimizing off-target effects on NHE4, NHE5, and NHE7 [ddp-4.com]. Unlike broad-spectrum inhibitors, DMA offers unmatched selectivity, enabling reproducible mechanistic studies of ion transport and cell survival under stress.

Mechanism of Action of 5-(N,N-dimethyl)-Amiloride (hydrochloride)

DMA competitively inhibits the Na+/H+ exchanger by binding to its extracellular domain. This prevents the antiport of intracellular H+ for extracellular Na+, resulting in intracellular acidification and reduced sodium influx. The inhibition constants (Ki) are 0.02 μM for NHE1, 0.25 μM for NHE2, and 14 μM for NHE3, showing strong specificity for NHE1 and NHE2 isoforms [APExBIO]. DMA does not significantly inhibit NHE4, NHE5, or NHE7 at standard working concentrations. By blocking proton extrusion, DMA impairs cell volume regulation and the recovery of pHi following acid load. In cardiac models, this mechanism underpins protection from ischemia-reperfusion injury by preventing excessive Na+ loading and subsequent Ca2+ overload, which can trigger contractile failure [nafamostatmesylate.com]. DMA also inhibits ouabain-sensitive ATPase activity and sodium-potassium ATPase, further modulating cellular ion gradients.

Evidence & Benchmarks

• DMA inhibits NHE1 with a Ki of 0.02 μM, NHE2 with 0.25 μM, and NHE3 with 14 μM, demonstrating marked isoform selectivity (APExBIO).
• DMA-mediated NHE1 inhibition prevents pathological sodium and pH shifts in cardiac ischemia-reperfusion injury, preserving contractility (Chen et al., 2021).
• DMA blocks ouabain-sensitive ATP hydrolysis and Na+/K+ ATPase activity in rat liver plasma membranes, implicating broader roles in ion transport (ddp-4.com).
• DMA reduces alanine uptake in isolated rat hepatocytes, suggesting effects on amino acid co-transport (ddp-4.com).
• DMA is soluble up to 30 mg/ml in DMSO or dimethylformamide, allowing for concentrated working stocks (APExBIO).

Applications, Limits & Misconceptions

DMA is a benchmark tool for investigating Na+/H+ exchange in cardiac, hepatic, and endothelial injury models. It is widely used to probe intracellular pH regulation, sodium ion transport, and the molecular sequelae of ischemia-reperfusion and sepsis-induced endothelial dysfunction. Its selectivity for NHE1/NHE2 makes it preferable to less specific amiloride analogs in mechanistic studies of pH and Na+ homeostasis [egf-receptor-substrate-eps15-acetyl.com]. This article extends these findings by detailing its validated use in translational models and highlighting its benchmark specificity.

For a more application-driven perspective on DMA in experimental workflows, see "5-(N,N-dimethyl)-Amiloride Hydrochloride: Precision NHE1 ..."—this article updates that guide by providing current evidence on isoform selectivity and translational endpoints. For a broader analysis of DMA's molecular and translational roles, "5-(N,N-dimethyl)-Amiloride Hydrochloride: Unraveling Na+/..." bridges mechanistic and clinical insights, while our current article offers more quantifiable benchmarks for cardiovascular and sepsis studies.

Common Pitfalls or Misconceptions

• DMA is not a pan-NHE inhibitor: It does not potently inhibit NHE4, NHE5, or NHE7 at standard concentrations.
• DMA is for research use only: Not approved for diagnostic or medical human/animal use (see APExBIO).
• Solutions are unstable long-term: DMA working stocks lose potency if stored in solution for extended periods; use promptly after preparation.
• DMA does not directly affect non-epithelial ion channels: Its primary target is the Na+/H+ exchanger; do not infer effects on other transporters without evidence.
• Not suitable for in vivo diagnostic imaging: DMA lacks features for imaging or tracer studies.

Workflow Integration & Parameters

DMA is supplied as a hydrochloride salt (MW = 294.1) and should be stored at -20°C. For cell-based assays, dissolve DMA in DMSO or dimethylformamide to a maximum of 30 mg/ml. Prepare working solutions fresh; avoid long-term storage in solution. Typical in vitro concentrations range from 0.01 to 10 μM, depending on isoform selectivity required. Confirm NHE1/NHE2 expression in the target system for optimal results. For ischemia-reperfusion models, pre-treat cells or tissues with DMA 5–30 minutes before induction of injury. Monitor pHi and Na+ levels using appropriate fluorescent or electrode-based methods. APExBIO’s C3505 formulation ensures batch-to-batch consistency for reproducible results (APExBIO).

Conclusion & Outlook

5-(N,N-dimethyl)-Amiloride (hydrochloride) is a gold standard NHE1 inhibitor for research on intracellular pH and sodium transport. Its potency and selectivity enable high-fidelity dissection of ion regulation in cardiovascular, hepatic, and endothelial models. By integrating DMA into mechanistic and translational assays, researchers can generate robust, reproducible data on the Na+/H+ exchange pathway. APExBIO’s C3505 kit provides validated, research-grade DMA for advanced ion transport and disease modeling. Future studies will extend its application in complex tissue models and multi-omics analyses of cellular stress responses.